Nancy A. Johnson

Array ( [id] => 1479480 [patent_doc_number] => 06451981 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Antibodies against lymphocyte-associated cell surface protein LAM-1' [patent_app_type] => B1 [patent_app_number] => 08/458808 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 2259 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451981.pdf [firstpage_image] =>[orig_patent_app_number] => 08458808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626422 [patent_doc_number] => 05686292 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Hepatocyte growth factor receptor antagonist antibodies and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/460368 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 10943 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686292.pdf [firstpage_image] =>[orig_patent_app_number] => 460368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3773392 [patent_doc_number] => 05817514 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'O.sup.6 -Methylguanine-DNA-methyltransferase (MGMT) specific antibodies' [patent_app_type] => 1 [patent_app_number] => 8/436464 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 7098 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817514.pdf [firstpage_image] =>[orig_patent_app_number] => 436464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4125581 [patent_doc_number] => 06033665 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Compositions and methods for modulating leukocyte adhesion to brain endothelial cells' [patent_app_type] => 1 [patent_app_number] => 8/457847 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 12824 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033665.pdf [firstpage_image] =>[orig_patent_app_number] => 457847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034414 [patent_doc_number] => 05994510 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Recombinant antibodies specific for TNF.alpha.' [patent_app_type] => 1 [patent_app_number] => 8/456418 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14546 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994510.pdf [firstpage_image] =>[orig_patent_app_number] => 456418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4251414 [patent_doc_number] => 06222020 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Antigens derived from the core protein of the human mammary epithelial mucin' [patent_app_type] => 1 [patent_app_number] => 8/456919 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 25 [patent_no_of_words] => 8396 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/222/06222020.pdf [firstpage_image] =>[orig_patent_app_number] => 456919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3733017 [patent_doc_number] => 05693758 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Immunoglobulin E competitor' [patent_app_type] => 1 [patent_app_number] => 8/454605 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7255 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 290 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693758.pdf [firstpage_image] =>[orig_patent_app_number] => 454605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3708104 [patent_doc_number] => 05654405 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Antbodies to human kerctinocyte growth factor (KGF) and related pharmaceuticals' [patent_app_type] => 1 [patent_app_number] => 8/455655 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 15498 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654405.pdf [firstpage_image] =>[orig_patent_app_number] => 455655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3990018 [patent_doc_number] => 05891706 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Human protocadherin-43 antibodies' [patent_app_type] => 1 [patent_app_number] => 8/453702 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18069 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891706.pdf [firstpage_image] =>[orig_patent_app_number] => 453702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690797 [patent_doc_number] => 05691454 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'APC antibodies' [patent_app_type] => 1 [patent_app_number] => 8/452654 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 42 [patent_no_of_words] => 23462 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691454.pdf [firstpage_image] =>[orig_patent_app_number] => 452654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3785184 [patent_doc_number] => 05736389 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'EBI nucleic acids' [patent_app_type] => 1 [patent_app_number] => 8/446919 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6600 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736389.pdf [firstpage_image] =>[orig_patent_app_number] => 446919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3517987 [patent_doc_number] => 05576422 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => 'MCC protein and antibody' [patent_app_type] => 1 [patent_app_number] => 8/445186 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 9255 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576422.pdf [firstpage_image] =>[orig_patent_app_number] => 445186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3802921 [patent_doc_number] => 05830676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Diagnosis with MCC' [patent_app_type] => 1 [patent_app_number] => 8/446550 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 9248 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830676.pdf [firstpage_image] =>[orig_patent_app_number] => 446550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3656132 [patent_doc_number] => 05658791 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-19 [patent_title] => 'Antibodies which specifically bind to proteins having tyrosine kinase activity, wherein said proteins have more than one tyrosine kinase domain, and no SH2 domains' [patent_app_type] => 1 [patent_app_number] => 8/446038 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 37 [patent_no_of_words] => 10764 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/658/05658791.pdf [firstpage_image] =>[orig_patent_app_number] => 446038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660185 [patent_doc_number] => 05624806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Antibodies to cardiac hypertrophy factor and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/442745 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 37056 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624806.pdf [firstpage_image] =>[orig_patent_app_number] => 442745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4010846 [patent_doc_number] => 05879898 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors' [patent_app_type] => 1 [patent_app_number] => 8/428138 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 15825 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/879/05879898.pdf [firstpage_image] =>[orig_patent_app_number] => 428138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3704333 [patent_doc_number] => 05654157 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Monoclonal antibodies to leukemia inhibitory factor and their use in immunoassays' [patent_app_type] => 1 [patent_app_number] => 8/438300 [patent_app_country] => US [patent_app_date] => 1995-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 6549 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654157.pdf [firstpage_image] =>[orig_patent_app_number] => 438300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662838 [patent_doc_number] => 05668003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Nucleic acid encoding monoclonal antibodies to leukemia inhibitory factor' [patent_app_type] => 1 [patent_app_number] => 8/438455 [patent_app_country] => US [patent_app_date] => 1995-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 6539 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668003.pdf [firstpage_image] =>[orig_patent_app_number] => 438455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659500 [patent_doc_number] => 05667780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Antibodies to SMDF' [patent_app_type] => 1 [patent_app_number] => 8/428926 [patent_app_country] => US [patent_app_date] => 1995-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 33731 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/667/05667780.pdf [firstpage_image] =>[orig_patent_app_number] => 428926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549275 [patent_doc_number] => 05573762 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy' [patent_app_type] => 1 [patent_app_number] => 8/428002 [patent_app_country] => US [patent_app_date] => 1995-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 14201 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/573/05573762.pdf [firstpage_image] =>[orig_patent_app_number] => 428002 [rel_patent_id] =>[rel_patent_doc_number] =>)